Growth Metrics

Bruker (BRKRP) Gains from Sales and Divestitures (2011 - 2025)

Bruker posted quarterly Gains from Sales and Divestitures of $299973.0 for Q4 2025, up 10.5% year-on-year from $271477.0 in Q4 2024, and up 10.5% on a QoQ basis from $271477.0 in Q4 2024.

Bruker (BRKRP) has 14 years of Gains from Sales and Divestitures data on file, last reported at $299973.0 in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures rose 10.5% year-over-year to $299973.0; the trailing twelve-month figure through Dec 2025 stood at $299973.0 (up 10.5% YoY), and the FY2025 full-year result was $299973.0, up 10.5% from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 stood at $299973.0, up from $271477.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $299973.0 in Q4 2025 and bottomed at $266395.0 in Q4 2023.
  • The 4-year median for Gains from Sales and Divestitures is $275082.0 (2022), against an average of $278804.6.
  • The widest annual swing landed in 2023, when Gains from Sales and Divestitures fell 5.23%; it then grew 10.5% in 2025.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $281096.0 in 2022, then declined by 5.23% to $266395.0 in 2023, then rose by 1.91% to $271477.0 in 2024, then grew by 10.5% to $299973.0 in 2025.
  • The last three Gains from Sales and Divestitures figures came in at $299973.0 (Q4 2025), $271477.0 (Q4 2024), and $266395.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Bruker - - 379.80 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 299,973.00
Dec 31, 2025 299,973.00
Dec 31, 2024 271,477.00
Dec 31, 2024 271,477.00
Dec 31, 2023 266,395.00
Dec 31, 2023 266,395.00
Dec 31, 2022 281,096.00
Dec 31, 2022 281,096.00
Sep 30, 2022 275,082.00
Sep 30, 2022 275,082.00
Dec 31, 2020 336,728.00
Dec 31, 2020 336,728.00
Sep 30, 2020 283,048.00
Sep 30, 2020 283,048.00
Jun 30, 2020 46,120.00
Jun 30, 2020 46,120.00
Mar 31, 2020 41,738.00
Mar 31, 2020 41,738.00
Dec 31, 2019 268,014.00
Dec 31, 2019 268,014.00
Sep 30, 2019 213,286.00
Sep 30, 2019 213,286.00
Jun 30, 2019 39,282.00
Jun 30, 2019 39,282.00
Mar 31, 2019 36,047.00
Mar 31, 2019 36,047.00
Dec 31, 2018 203,144.00
Dec 31, 2018 203,144.00
Sep 30, 2018 145,356.00
Sep 30, 2018 145,356.00
Jun 30, 2018 11,584.00
Jun 30, 2018 11,584.00
Mar 31, 2018 43,052.00
Mar 31, 2018 43,052.00
Dec 31, 2017 82,924.00
Dec 31, 2017 82,924.00
Sep 30, 2017 8,692.00
Sep 30, 2017 8,692.00
Jun 30, 2017 11,584.00
Jun 30, 2017 11,584.00
Mar 31, 2017 3,276.00
Mar 31, 2017 3,276.00
Sep 30, 2016 81,024.00
Sep 30, 2016 81,024.00
Jun 30, 2016 9,683.00
Jun 30, 2016 9,683.00
Sep 30, 2015 56,395.00
Sep 30, 2015 56,395.00
Jun 30, 2015 9,683.00
Jun 30, 2015 9,683.00
Mar 31, 2015 1,375.00
Mar 31, 2015 1,375.00
Dec 31, 2014 160,352.00
Dec 31, 2014 160,352.00
Sep 30, 2014 160,352.00
Sep 30, 2014 160,352.00
Jun 30, 2014 100,536.00
Jun 30, 2014 100,536.00
Mar 31, 2014 1,375.00
Mar 31, 2014 1,375.00
Dec 31, 2013 93,646.00
Dec 31, 2013 93,646.00
Sep 30, 2013 93,646.00
Sep 30, 2013 93,646.00
Jun 30, 2013 45,705.00
Jun 30, 2013 45,705.00
Mar 31, 2013 11,100.00
Mar 31, 2013 11,100.00
Dec 31, 2012 82,638.00
Dec 31, 2012 82,638.00
Sep 30, 2012 73,446.00
Sep 30, 2012 73,446.00
Jun 30, 2012 55,574.00
Jun 30, 2012 55,574.00
Mar 31, 2012 24,210.00
Mar 31, 2012 24,210.00
Dec 31, 2011 167,549.00
Dec 31, 2011 167,549.00
Sep 30, 2011 -158,358.00
Sep 30, 2011 -158,358.00
Jun 30, 2011 -46,420.00
Jun 30, 2011 -46,420.00